References

  1. World Health Organization. Global tuberculosis control 2009: epidemiology, strategy, financing. 1st ed. Geneva: WHO Press; c2009. 137 p.
  2. USAID: from the American people (Internet). Washington: United States Agency for International Development; 2009. Infectious diseases: Philippines; February 2009 (cited 2009 May 20) Available from: http://www.usaid.gov/our_work/global_health/id/tuberculosis/countries/asia/philippines_profile.html
  3. Phillips PH. Toxic and deficient optic neuropathies. 6th ed. Philadelphia: Lippincott Williams and Wilkins; c2005. 455 p (Miller NR, Newman NJ, Biousse V, Kerrison JB eds. Walsh & Hoyt’s Clinical Neuro-Ophthalmology; Vol. 1)
  4. Carr RE, Henkind P. Ocular manifestations of ethambutol. Arch Ophthalmol 1962;67:566-571.
  5. KOZAK SF, INDERLIED CB, HSU HY, HELLER KB, SADUN AA. The role of copper on ethambutol's antimicrobial action and implications for ethambutol-induced optic neuropathy. Diagn Microbiol Infect Dis 1998;30(2): 83-7.
  6. Nazari AM, Kobarfard F, Tabarsi P, Salamzadeh J. Serum copper (cu) alterations in pulmonary tuberculosis patients under treatment with ethambutol. Biol Trace Elem Res 2009;128(2):161-6.
  7. Cole A, May PM, Williams DR. Metal binding by pharmaceuticals. Part 1. Copper(II) and zinc(II) interactions following ethambutol administration. Agents Actions 1981;11(3):296-305.
  8. Citron KM. Ethambutol: a review with special reference to ocular toxicity. Tubercle 1969;50(Suppl):32s-6s.
  9. KASS I. Chemotherapy regimens used in retreatment of pulmonary tuberculosis. Part II. Observations on the efficacy of combinations of ethambutol, capreomycin and companion drugs, including 4-4 diisoamyloxythiosemicarbanilide. Tubercle 1965;46:166–177.
  10. Leibold JE. The ocular toxicity of ethambutol and its relation to dose. Ann NY Acad Sci 1966;135(2):904–9.
  11. Pyle MM. Ethambutol in the retreatment and primary treatment tuberculosis: a four-year clinical investigation. Ann NY Acad Sci 1966;135:835-845.
  12. De Palma P, Franco F, Bragliani G, Michetti L, Marescotti A, Pirazzoli G, Fiorenza M. The incidence of optic neuropathy in 84 patients treated with ethambutol. Metab Pediatr Syst Ophthalmol 1989;12(1-3):80-2.
  13. Roussos T, Tsolkas A. The toxicity of myambutol on the human eye. Ann Ophthalmol 1970;2:577-580.
  14. Fang JT, Chen YC, Chang MY. Ethambutol-induced optic neuritis in patients with end stage renal disease on hemodialysis: two case reports and literature review. Ren Fail 2004;26(2):189-193.
  15. Barron GJ, Tepper L, Iovine G. Ocular toxicity from ethambutol. Am J Ophthalmol 1974;77(2):256-260.
  16. Kahana LM. Toxic ocular effects of ethambutol. Can Med Assoc J1987;137(3):213-6.
  17. Choi SY, Hwang JM. Optic neuropathy associated with ethambutol in Koreans. Korean J Ophthalmol 1997;11(2):106-110.
  18. Tsai RK, Lee YH. Reversibility of ethambutol optic neuropathy. J Ocul Pharmacol Ther 1997;13:473-7.
  19. Trusiewicz D. Farnsworth 100-hue test in diagnosis of ethambutol-induced damage to optic nerve. Ophthalmologica 1975;171:425-431.
  20. Polak BC, Leys M, van Lith GH. Blue-yellow colour vision changes as early symptoms of ethambutol oculotoxicity. Ophthalmologica 1985;191:223-6
  21. Brontë-Stewart J, Pettigrew AR, Foulds WS. Toxic optic neuropathy and its experimental production. Trans Ophthalmol Soc UK 1976;96:355-8.
  22. Kumar A, Sandamouli S, Verma L, Tewari HK, Khosla PK. Ocular ethambutol toxicity: is it reversible? J Clin Neuroophthalmol 1993;13(1):15-7.
  23. Inocencio FP, Castillo TR. Toxic optic neuropathy secondary to ethambutol. Philipp J Ophthalmol 1999;24(2):65-8.
  24. Jimenez-Lucho VE, Busto RD, Odel J. Isonizid and ethambutol as a cause of optic neuropathy. Eur J Respir Dis 1987;71:42-5.
  25. Cayley FE, Majumdar SK. Ocular toxicity due to rifampicin. Br Med J 1976;1(6003): 199–200.
  26. Sivakumaran P, Harrison AC, Marschner J, Martin P. Ocular toxicity from ethambutol: a review of four cases and recommended precautions. NZ Med J 1998;111:428-430.
  27. Kho RC. Ethambutol-related toxic optic neuropathy in the Philippines. Paper presented at: The Joint Meeting of the Philippine Academy of Ophthalmology and American Academy of Ophthalmology (PAO-AAO Joint Meeting); 2005 Nov 28 – Dec 1; Manila, Philippines.
  28. Tamesis JM Jr, Cloma A, Bascara A. Ethambutol toxic optic neuropathy in the Philippines. Neuro Ophthalmol Jpn 2002;19:261-6.
  29. Chan RYC, Kwok AKH. Ocular toxicity of ethambutol. Hong Kong Med J 2006;12:56-60.
  30. Lee EJ, Kim SJ, Choung HK, Kim JH, Yu YS. Incidence and clinical features of ethambutol-induced optic neuropathy in Korea. J Neuro-Ophthalmol 2008; 28:269-277.
  31. Lim SA. Ethambutol-associated optic neuropathy. Ann Acad Med Singapore 2006;35:274-8.
  32. Tan AK, Mallika PS, Aziz S, Asok T, Intan G. Ethambutol ocular toxicity in a patient with pulmonary tuberculosis: a case report. Malaysian Family Physician 2008;3(2):87-90.
  33. Chee YC. Ocular toxicity from ethambutol. Singapore Med 1981;22:78-80.
  34. Kho RC. Ethambutol-related toxic optic neuropathy in the Philippines: local issues and controversies. Paper presented at: Controversies in neuro-ophthalmology. The24th Congress of the Asia-Pacific Academy of Ophthalmology (APAO-AAO Joint Meeting); 2009 May 16-19; Bali, Indonesia.
  35. Villanueva ME, Regner LV. Occurrence of vision problems among patients taking anti-tuberculosis medications. Paper presented at: Look the Future in the Eye. The Philippine Academy of Ophthalmology Annual Meeting;2004 November 18-20; Manila, Philippines.
  36. Bernardo EM 3rd, Cloma LAD, Uriate G, Tamesis JM Jr. Ethambutol toxic optic neuropathy: a patient demographic risk profile. Paper presented at: Look the Future in the Eye. The Philippine Academy of Ophthalmology Annual Meeting;2004 November 18-20; Manila, Philippines.
  37. Bernardo EM 3rd, Tamesis JM Jr, Cloma LAD, Valera EG, Sy CA. Descriptive histopathologic animal study of ethambutol toxic optic neuropathy in the rat model. Paper presented at: Asian Neuro-ophthalmology Society-International Neuro-ophthalmology Society Joint Meeting;2006 November 29-December2; Tokyo, Japan.
  38. Noche RR, Nicolas MG, Gonzaga NC. A study of the evolution of optic neuritis caused by ethambutol in rabbits. Phil J Microbiol Infect Dis 1987;16(2)42-6.
  39. Joint Tuberculosis Committee of the British Thoracic Society. Chemotherapy and management of tuberculosis in the United Kingdom: recommendations 1998. Thorax 1998;53:536-48.
  40. Tuberculosis and Chest Service, Department of Health. Preventive measures against drug-induced ocular toxicity during anti-tuberculosis treatment (general recommendations). Hong Kong: Department of Health Annual Report 2002.